Skip to main content
. 2010 Apr 27;12(3):338–347. doi: 10.1208/s12248-010-9193-1

Fig. 2.

Fig. 2

Bacterial burden in lungs and spleens of guinea pigs immunized with single doses of the different formulations after challenge with MTB H37Rv (BCG = BCG solution; PLGA ctl = blank microparticles; P-rAg85B = microparticles containing rAg85B; P-rAg85B-TDB = microparticles containing rAg85B and adjuvant TDB (average ± SD, n = 6)